These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8004480)

  • 1. Determination of galactose elimination capacity after intravenous administration in patients with chronic liver diseases.
    Kupcová V; Turecký L; Brixová E
    Bratisl Lek Listy; 1993 Jul; 94(7):354-60. PubMed ID: 8004480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of galactose eliminating capacity after intravenous administration--a liver function test].
    Kupcová V; Turecký L; Brixová E
    Vnitr Lek; 1992 Oct; 38(10):992-9. PubMed ID: 1481380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The galactose eliminating capacity of the liver and its protein synthesis function in chronic liver diseases].
    Kupcová V; Turecký L; Brixová E
    Bratisl Lek Listy; 1994 Sep; 95(9):395-401. PubMed ID: 7812845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of liver function using a novel galactose single point method.
    Tang HS; Hu OY
    Digestion; 1992; 52(3-4):222-31. PubMed ID: 1334011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatic galactose elimination capacity measured after a single intravenous injection of galactose in normal adults and in patients with various liver diseases.
    den Blaauwen DH; Thijs LG
    Neth J Med; 1973; 16(1):2-13. PubMed ID: 4696952
    [No Abstract]   [Full Text] [Related]  

  • 9. Splanchnic galactose uptake in patients with cirrhosis during continuous infusion.
    Lindskov J; Ranek L; Tygstrup N; Winkler K
    Clin Physiol; 1983 Apr; 3(2):179-85. PubMed ID: 6682739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C.
    Mion F; Rousseau M; Scoazec JY; Berger F; Minaire Y
    Eur J Clin Invest; 1999 Jul; 29(7):624-9. PubMed ID: 10411669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia induced by fructose load in liver cirrhosis.
    Budillon G; Citarella C; Loguercio C; Nardone G; Sicolo P; Del Vecchio Blanco C
    Ital J Gastroenterol; 1992 Sep; 24(7):373-7. PubMed ID: 1392016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
    Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
    Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainty in liver function assessment on the basis of single-point galactose concentration.
    Fabbri A; Bianchi G; Brizi M; Zoli M; Marchesini G
    Digestion; 1997; 58(4):379-83. PubMed ID: 9324166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Galactose elimination capacity, a reliable test for quantitative comprehension of the liver function].
    Heri M; Bircher J
    Schweiz Med Wochenschr; 1971 May; 101(20):735-6. PubMed ID: 5578402
    [No Abstract]   [Full Text] [Related]  

  • 16. The galactose elimination capacity test: a study of the technique based on the analysis of 868 measurements.
    Fabbri A; Bianchi G; Motta E; Brizi M; Zoli M; Marchesini G
    Am J Gastroenterol; 1996 May; 91(5):991-6. PubMed ID: 8633594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What does the BSP retention measure? Comparison of BSP-transport maximum, storage capacity and capacity for elimination of galactose].
    Imesch B; Häcki W; Bircher J
    Schweiz Med Wochenschr; 1973 Mar; 103(11):397-403. PubMed ID: 4691799
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of galactose in human blood by high-performance liquid chromatography: comparison with an enzymatic method and application to the pharmacokinetic study of galactose in patients with liver dysfunction.
    Hu OY; Hu TM; Tang HS
    J Pharm Sci; 1995 Feb; 84(2):231-5. PubMed ID: 7738808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splanchnic galactose uptake in patients with cirrhosis following single injection.
    Ranek L; Lindskov J; Tygstrup N; Winkler K
    Clin Physiol; 1983 Apr; 3(2):173-8. PubMed ID: 6682738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver function evaluation in dogs by the galactose load test.
    Bernardini D; Poser H; Giuliani A; Tacchio G; Franceschi F
    Vet Res Commun; 2005 Aug; 29 Suppl 2():277-80. PubMed ID: 16244974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.